Treatment of Type2 Diabetes
-
Janssen’s SGLT-2 Drugs and Risk of Amputations: What Happened, and What’s Next?
The European regulators have applied their amputation risk warning to all Janssen products in the SGLT-2 inhibitor class. But FDA…
Read More » -
Keeping Diabetic Eye Disease In Check
Here’s our reminder that you need to visit your eye doctor regularly to check for signs of diabetic retinopathy. We’re…
Read More » -
Having A Look At The American Diabetes Association’s 2017 Clinical Practice Update
Many T2D’s treat almost exclusively with the family doctor. The American Diabetes Association publishes an annual update of its clinical…
Read More » -
FDA To Require Prominent Amputation Risk Warning for Canagliflozin SGLT-2 Inhibitors
Post-market clinical trials of the Type 2 medication canagliflozin to assess cardiovascular and renal risks have affirmed a suspected link…
Read More » -
A Lesson From The World’s Second Oldest Mode of Human Self-Propulsion
A 105-year-old cyclist upends the idea that exercise gets us only so far.
Read More » -
A Common Sense Approach to Nutrition
A lesson from the environmental movement – reduce and recycle. Here’s the “reduce” side of the equation.
Read More » -
The Importance of Dental Health
People who have Type 2 have double the reasons to maintain good dental health.
Read More » -
High Blood Pressure Target Puts People with Diabetes at Risk
A move to raise blood pressure goals in Sweden is questioned by researchers.
Read More » -
Gene Therapy for Type 2 Diabetes Improves Insulin Sensitivity in Mice
One infusion improved blood sugar levels for seven weeks.
Read More » -
Researchers Find Sulfonylureas Don’t Pose a Cardiovascular Risk
A review finds this drug class is safe and effective, as well as cheap.
Read More »
